Related Experiment Video
Updated: Aug 12, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study
Lisa R Sun1, Alexandra Linds2, Mukta Sharma3
1Division of Pediatric Neurology, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland; Division of Cerebrovascular Neurology, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland.
Insights
Cancer significantly increases the risk of stroke in children. Children with cancer experienced more recurrent strokes and received less treatment for stroke prevention.
Area of Science:
- Pediatric Neurology
- Pediatric Oncology
- Hematology
Background:
- The prevalence of cancer in pediatric stroke patients is not well-established.
- This study investigates the association between cancer and ischemic stroke in children.
Purpose of the Study:
- To evaluate the incidence and characteristics of cancer-associated childhood ischemic stroke.
- To compare stroke treatment and recurrence rates in children with and without cancer.
Main Methods:
- Analysis of data from the International Pediatric Stroke Study (2003-2019).
- Inclusion of children aged 29 days to 19 years with arterial ischemic stroke or cerebral sinovenous thrombosis.
- Comparison of treatment and recurrence between cancer and non-cancer groups using statistical tests.
Main Results:
- Cancer was present in 3.3% of arterial ischemic stroke cases and 10.7% of cerebral sinovenous thrombosis cases.
- Brain tumors and hematologic malignancies were common cancer types.
- Children with cancer received less antithrombotic/anticoagulant therapy and had higher rates of recurrent stroke.
Conclusions:
- Cancer is a significant risk factor for both initial and recurrent strokes in children.
- There is a need for specific stroke prevention strategies for pediatric cancer patients.
Background:
The prevalence of cancer among children with stroke is unknown. This study sought to evaluate cancer- and tumor-associated childhood ischemic stroke in a multinational pediatric stroke registry.
Methods:
Children aged 29 days to less than 19 years with arterial ischemic stroke or cerebral sinovenous thrombosis enrolled in the International Pediatric Stroke Study between January 2003 and June 2019 were included. Data including stroke treatment and recurrence were compared between subjects with and without cancer using Wilcoxon rank sum and chi-square tests.
Results:
Cancer or tumor was present in 99 of 2968 children (3.3%) with arterial ischemic stroke and 64 of 596 children (10.7%) with cerebral sinovenous thrombosis. Among children in whom cancer type was identified, 42 of 88 arterial ischemic stroke cases (48%) had brain tumors and 35 (40%) had hematologic malignancies; 45 of 58 cerebral sinovenous thrombosis cases (78%) had hematologic malignancies and eight (14%) had brain tumors. Of 54 cancer-associated arterial ischemic stroke cases with a known cause, 34 (63%) were due to arteriopathy and nine (17%) were due to cardioembolism. Of 46 cancer-associated cerebral sinovenous thrombosis cases with a known cause, 41 (89%) were related to chemotherapy-induced or other prothrombotic states. Children with cancer were less likely than children without cancer to receive antithrombotic therapy for arterial ischemic stroke (58% vs 80%, P = 0.007) and anticoagulation for cerebral sinovenous thrombosis (71% vs 87%, P = 0.046). Recurrent arterial ischemic stroke (5% vs 2%, P = 0.04) and cerebral sinovenous thrombosis (5% vs 1%, P = 0.006) were more common among children with cancer.
Conclusions:
Cancer is an important risk factor for incident and recurrent childhood stroke. Stroke prevention strategies for children with cancer are needed.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Transient Ischemic Attack l: Introduction

